Effect of coadministration of ezetimibe with statin therapy versus statin therapy alone on flow mediated vasodilation in patients with coronary artery disease.

Trial Profile

Effect of coadministration of ezetimibe with statin therapy versus statin therapy alone on flow mediated vasodilation in patients with coronary artery disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2009

At a glance

  • Drugs Ezetimibe (Primary) ; Atorvastatin
  • Indications Coronary artery disease; Dyslipidaemias
  • Focus Pharmacodynamics
  • Acronyms CEZAR
  • Most Recent Events

    • 01 Jul 2009 Primary endpoint 'Change in flow-mediated dilation' has been met.
    • 01 Jul 2009 Results published in Atherosclerosis.
    • 03 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top